AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases
Xiaoliang Wu(Guizhou Provincial People's Hospital), C. Patrick(Penn State Milton S. Hershey Medical Center)
Cited by 39
Related Papers
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
|Journal of Hematology & Oncology|2019|634
<i>NRG1</i> fusions in solid tumors.
|Journal of Clinical Oncology|2023|7
PP01.14 Paired Sample Analyses of NSCLC After SCLC Transformation
|Journal of Thoracic Oncology|2025|0